-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On June 7th, Rongchang Biologics independently developed a new ADC drug for injection Vidicuzumab (code: RC48, trade name: Aidixi) to enter the approval stage and will be approved in the near future
.
This will be the first domestically produced ADC
ADC drugs are a new type of biological drugs conjugated by monoclonal antibodies, linkers and toxins, which can perform precise attacks on tumor cells
.
RC48 adopts a new humanized antibody with stronger affinity and better endocytosis effect, and uses advanced linkers and small molecule toxin drugs, which can effectively kill tumors